fullerene c60 has been researched along with Animal Mammary Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Guo, M; Liu, Y; Shao, L; Tang, J; Wu, Y; Zhang, R; Zhang, S; Zhao, Y | 1 |
1 other study(ies) available for fullerene c60 and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Nucleosome-inspired nanocarrier obtains encapsulation efficiency enhancement and side effects reduction in chemotherapy by using fullerenol assembled with doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Liberation; Female; Fullerenes; Mammary Neoplasms, Animal; Mice; Models, Molecular; Polyesters; Polyethylene Glycols | 2018 |